GBLB:EURONEXT BRUSSELSGroupe Bruxelles Lambert SA Analysis
Data as of 2026-03-14 - not real-time
$91.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Groupe Bruxelles Lambert is trading at its 20‑day simple moving average with a bullish trend direction and rising volume, suggesting short‑term buying pressure. The price is perched on a key support around €91 and faces resistance near €100, while the RSI sits in the mid‑30s, hinting at modest oversold conditions. However, the MACD histogram remains negative, signaling lingering bearish momentum. On the fundamentals side, the stock offers an attractive dividend yield of about 6 % but the payout ratio exceeds 400 %, raising concerns about sustainability. The price‑to‑earnings multiple is roughly five times the industry average, pointing to significant overvaluation despite a price‑to‑book below 1. Recent news of the group divesting its stake in Umicore reflects a strategic portfolio simplification that could improve focus but also reduces exposure to a high‑margin business.
The risk profile is marked by high 30‑day volatility and limited liquidity, while beta is near zero, indicating low market correlation. Sector‑specific regulatory and geographic exposures are moderate, but the combination of an inflated valuation, unsustainable dividend policy, and volatile price action suggests a cautious stance. Investors may consider holding for the near term while monitoring earnings trends and cash‑flow generation before committing to a longer‑term position.
The risk profile is marked by high 30‑day volatility and limited liquidity, while beta is near zero, indicating low market correlation. Sector‑specific regulatory and geographic exposures are moderate, but the combination of an inflated valuation, unsustainable dividend policy, and volatile price action suggests a cautious stance. Investors may consider holding for the near term while monitoring earnings trends and cash‑flow generation before committing to a longer‑term position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish trend and rising volume
- RSI indicating near‑oversold conditions
- Negative MACD histogram suggesting caution
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- High PE relative to industry peers
- Unsustainable dividend payout ratio
- Portfolio simplification through Umicore sale
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Significant overvaluation
- Lack of earnings growth and zero ROE
- Elevated volatility and liquidity constraints
Key Metrics & Analysis
Financial Health
Profit Margin-2.00%
P/E Ratio78.4
Debt/Equity53.49
P/B Ratio0.8
Industry P/E16.4
Technical Analysis
TrendBullish
RSI36.5
Support$91.00
Resistance$100.00
MA 20$95.90
MA 50$93.59
MA 200$88.43
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
GradeOvervalued
TypeValue
Dividend Yield6.10%
Risk Assessment
Beta-0.02
Volatility31.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.